Market Analysis and Price Projections for NDC 51407-0854: ERYTHROMYCIN
Introduction to NDC 51407-0854
The National Drug Code (NDC) 51407-0854 corresponds to ERYTHROMYCIN, a medication supplied by Golden State Medical Supply, Inc. This antibiotic is widely used to treat various bacterial infections.
Current Market Context
Pharmaceutical Market Growth
The overall prescription drug market is expected to grow at a CAGR of 9% through 2030, driven by increasing demand for advanced treatments and innovative therapies[2].
Specific Drug Trends
For ERYTHROMYCIN, the market trends are influenced by several factors, including the availability of generic versions, regulatory changes, and shifts in bacterial resistance patterns.
Pricing and Cost Analysis
Current Pricing
As of the latest available data, the pricing for ERYTHROMYCIN under NDC 51407-0854 is not explicitly provided. However, we can look at similar antibiotics and their pricing trends to make some inferences.
For example, the prices of other antibiotics and medications supplied by Golden State Medical Supply, Inc. have shown variability over time. The price per unit for CHLORPROMAZINE HCL 200MG TAB, another drug from the same supplier, has ranged from $2.47520 to $2.49870 per unit over different periods[1].
Wholesale and Pharmacy Costs
Wholesale prices for antibiotics can fluctuate based on supply chain dynamics, manufacturing costs, and regulatory factors. For ERYTHROMYCIN, the wholesale cost would typically be lower than the pharmacy cost, which includes additional margins for distribution and retail.
Price Projections for 2025
Overall Drug Price Inflation
The Vizient Pharmacy Market Outlook projects a 0.00% overall drug price inflation rate for the period from January 1, 2025, to December 31, 2025. This suggests a stable pricing environment for many pharmaceuticals, including antibiotics like ERYTHROMYCIN[4].
Specific Projections for ERYTHROMYCIN
Given the stable inflation rate and the generic nature of ERYTHROMYCIN, it is likely that the prices for this drug will remain relatively stable in 2025. Here are some key points to consider:
- Stable Demand: ERYTHROMYCIN is a well-established antibiotic with consistent demand, which typically leads to stable pricing.
- Generic Availability: As a generic drug, ERYTHROMYCIN faces competition from multiple manufacturers, which can help keep prices stable or even reduce them slightly.
- Regulatory Environment: Any significant regulatory changes could impact pricing, but as of now, there are no indications of major changes that would affect ERYTHROMYCIN specifically.
Impact of Technological and Data Trends
Role of AI and Health Tech
The increasing adoption of artificial intelligence (AI) and health tech in the pharmaceutical industry can influence pricing and market dynamics. For instance, AI can help in optimizing supply chains and reducing manufacturing costs, which could lead to more competitive pricing for drugs like ERYTHROMYCIN[3].
Use of External Data
Pharmaceutical companies are increasingly using reliable external data to train internal data science models. This trend can lead to better decision-making and potentially more efficient pricing strategies, although it may not directly impact the price of a specific generic drug like ERYTHROMYCIN in the short term[3].
Conclusion on Market Analysis and Price Projections
Given the stable market conditions, generic nature of the drug, and the absence of significant regulatory or technological disruptions, the price of ERYTHROMYCIN under NDC 51407-0854 is likely to remain stable in 2025.
Key Takeaways
- Stable Pricing Environment: The overall drug price inflation rate is projected to be 0.00% for 2025, indicating stable prices.
- Generic Competition: ERYTHROMYCIN, being a generic drug, faces competition that helps maintain stable prices.
- Technological Trends: While AI and health tech can optimize supply chains and reduce costs, their immediate impact on ERYTHROMYCIN pricing is minimal.
- Regulatory Stability: No significant regulatory changes are expected to affect ERYTHROMYCIN pricing in 2025.
FAQs
Q: What is the current price range for ERYTHROMYCIN under NDC 51407-0854?
A: The current price range for ERYTHROMYCIN under NDC 51407-0854 is not explicitly provided, but it can be inferred to be stable based on similar antibiotic pricing trends.
Q: How does the overall pharmaceutical market growth affect ERYTHROMYCIN pricing?
A: The overall pharmaceutical market growth does not directly impact the pricing of a generic drug like ERYTHROMYCIN, as its price is more influenced by competition and supply chain dynamics.
Q: What role does AI play in the pricing of pharmaceuticals like ERYTHROMYCIN?
A: AI can help in optimizing supply chains and reducing manufacturing costs, but its immediate impact on the pricing of a specific generic drug like ERYTHROMYCIN is minimal.
Q: Are there any regulatory changes expected to affect ERYTHROMYCIN pricing in 2025?
A: As of now, there are no indications of significant regulatory changes that would affect ERYTHROMYCIN pricing in 2025.
Q: How does the use of external data impact pharmaceutical pricing?
A: The use of external data can help pharmaceutical companies in better decision-making and potentially more efficient pricing strategies, but it may not directly impact the price of a specific generic drug like ERYTHROMYCIN in the short term.
Sources
- DrugPatentWatch - Latest drug prices and trends for NDC 51407-0438
- DrugPatentWatch - Latest drug prices and trends for NDC 00054-0319
- Intelligencia.ai - 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch
- Vizient Inc. - Pharmacy Market Outlook Summer 2024
- FindACode - Golden State Medical Supply, Inc. - List of Drugs - NDC Labeler
